Skip Navigation

Alzheimer's disease - donepezil, rivastigmine and galantamine (replaced by TA111)

Alzheimer's disease (mild to moderate) - donepezil, rivastigmine and galantamine

Guidance type:  Technology appraisal
Date issued:  January 2001

We will consult on our review plans for this guidance in December 2003.
Reference:  TA19

Summary

This guidance has been updated and replaced by TA111 Alzheimer's disease donepezil, galantamine, rivastigmine (review) and memantine.
Top

Documents

For healthcare professionals

  • None found

For patients, carers and the public

  • None found

Background information

Implementing this guidance

Any further information NICE has produced to help the NHS implement this guideline locally is linked to below:

  • None found
Top

Search NICE guidance


Advanced guidance search

Related information

See NICE guidance in practice

Related guidance

Click the links below to see guidance on similar topics

Order NICE guidance

Order printed copies of our guidance